1. Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir. Issue 3 (16th July 2013) Authors: McPhee, Fiona; Hernandez, Dennis; Yu, Fei; Ueland, Joseph; Monikowski, Aaron; Carifa, Arlene; Falk, Paul; Wang, Chunfu; Fridell, Robert; Eley, Timothy; Zhou, Nannan; Gardiner, David Journal: Hepatology Issue: Volume 58:Issue 3(2013:Sep.) Page Start: 902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TPP903, a novel anti-rat C5 IgG1, potently inhibits C5 activation in vitro and in vivo. (October 2018) Authors: Kim, SungKwon; Sun, Fang; Voegtli, Walter; Chen, Meng; Ahasan, Muhammad; Monikowski, Aaron; Barkowski-Clark, Susan; Gu, Zhenyu; Johnson, Krista Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Virological Escape in HCV Genotype-1-Infected Patients Receiving Daclatasvir plus Ribavirin and Peginterferon Alfa-2A or Alfa-2B. Issue 5 (July 2014) Authors: McPhee, Fiona; Hernandez, Dennis; Zhou, Nannan; Yu, Fei; Ueland, Joseph; Monikowski, Aaron; Chayama, Kazuaki; Toyota, Joji; Izumi, Namiki; Yokosuka, Osamu; Kawada, Norifumi; Osaki, Yukio; Hughes, Eric A; Watanabe, Hideaki; Ishikawa, Hiroki; Kumada, Hiromitsu Journal: Antiviral therapy Issue: Volume 19:Issue 5(2014) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗